Cassady Schiller Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Cassady Schiller Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$12.4K	Hold	150	–	–	﹤0.01%	323
2024 Q3	$13K	Hold	150	–	–	﹤0.01%	306
2024 Q2	$12.3K	Hold	150	–	–	0.01%	303
2024 Q1	$12K	Hold	150	–	–	0.01%	325
2023 Q4	$11.4K	Hold	150	–	–	0.01%	316
2023 Q3	$10.9K	Hold	150	–	–	0.01%	323
2023 Q2	$11.3K	Hold	150	–	–	0.01%	327
2023 Q1	$11.4K	Hold	150	–	–	0.01%	316
2022 Q4	$11.8K	Buy	+150	New	+$11.5K	0.01%	306
2022 Q1	–	Sell	-150	Closed	-$12K	–	464
2021 Q4	$12K	Buy	+150	New	+$11.9K	0.01%	306

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

MWM

MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Cassady Schiller Wealth Management's PJP Position: Q4 2024 in Review

Cassady Schiller Wealth Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q4 2024 at 150 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

Cassady Schiller Wealth Management first reported a position in PJP in Q4 2021 and has held it in 10 quarters since. The position peaked at $13K in Q3 2024. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2024.

Cassady Schiller Wealth Management held 150 shares of Invesco Pharmaceuticals ETF worth $12.4K as of Q4 2024.
Cassady Schiller Wealth Management left its Invesco Pharmaceuticals ETF share count unchanged in Q4 2024.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #323 holding.
Cassady Schiller Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2021 and has held it in 10 quarters since.
Cassady Schiller Wealth Management's Invesco Pharmaceuticals ETF position peaked at $13K in Q3 2024.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.